Publication: Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study.
dc.contributor.author | Garcia-Escobar, E | |
dc.contributor.author | Valdes, S | |
dc.contributor.author | Soriguer, F | |
dc.contributor.author | Vendrell, J | |
dc.contributor.author | Urrutia-Etxebarria, I M | |
dc.contributor.author | Maldonado-Araque, C | |
dc.contributor.author | Ortega, E | |
dc.contributor.author | Ocon, P | |
dc.contributor.author | Montanya, E | |
dc.contributor.author | Menendez, E | |
dc.contributor.author | Lago-Sampedro, A | |
dc.contributor.author | Gonzalez-Frutos, T | |
dc.contributor.author | Gomis, R | |
dc.contributor.author | Goday, A | |
dc.contributor.author | Garcia-Serrano, S | |
dc.contributor.author | Galan-Garcia, J L | |
dc.contributor.author | Castell, C | |
dc.contributor.author | Bordiu, E | |
dc.contributor.author | Badía, R | |
dc.contributor.author | Aguilera-Venegas, G | |
dc.contributor.author | Girbes, J | |
dc.contributor.author | Gaztambide, S | |
dc.contributor.author | Delgado, E | |
dc.contributor.author | Chaves, F J | |
dc.contributor.author | Castaño, L | |
dc.contributor.author | Calle-Pascual, A | |
dc.contributor.author | Rojo-Martinez, G | |
dc.contributor.author | Franch-Nadal, J | |
dc.contributor.funder | CIBERDEM (Ministerio de Economía, Industria y Competitividad | |
dc.contributor.funder | Ministerio de Sanidad, Servicios Sociales e Igualdad-ISCIII | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | European Regional Development Fund (ERDF) “A way to build Europe”. | |
dc.contributor.funder | Consejería de Salud, Junta de Andalucía, Spain | |
dc.date.accessioned | 2023-02-09T11:46:38Z | |
dc.date.available | 2023-02-09T11:46:38Z | |
dc.date.issued | 2021-08-12 | |
dc.description.abstract | Our aim was to evaluate whether fatty liver index (FLI) is associated with the risk of type 2 diabetes (T2DM) development within the Spanish adult population and according to their prediabetes status; additionally, to examine its incremental predictive value regarding traditional risk factors. A total of 2260 subjects (Prediabetes: 641 subjects, normoglycemia: 1619 subjects) from the Di@bet.es cohort study were studied. Socio-demographic, anthropometric, clinical data and survey on habits were recorded. An oral glucose tolerance test was performed and fasting determinations of glucose, lipids and insulin were made. FLI was calculated and classified into three categories: Low ( 60). In total, 143 people developed diabetes at follow-up. The presence of a high FLI category was in all cases a significant independent risk factor for the development of diabetes. The inclusion of FLI categories in prediction models based on different conventional T2DM risk factors significantly increase the prediction power of the models when all the population was considered. According to our results, FLI might be considered an early indicator of T2DM development even under normoglycemic condition. The data also suggest that FLI could provide additional information for the prediction of T2DM in models based on conventional risk factors. | |
dc.description.version | Si | |
dc.identifier.citation | García-Escobar E, Valdés S, Soriguer F, Vendrell J, Urrutia-Etxebarria IM, Maldonado-Araque C, et al. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. Sci Rep. 2021 Aug 12;11(1):16453 | |
dc.identifier.doi | 10.1038/s41598-021-95546-x | |
dc.identifier.essn | 2045-2322 | |
dc.identifier.pmc | PMC8361016 | |
dc.identifier.pmid | 34385479 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361016/pdf | |
dc.identifier.unpaywallURL | https://www.nature.com/articles/s41598-021-95546-x.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/18365 | |
dc.issue.number | 1 | |
dc.journal.title | Scientific reports | |
dc.journal.titleabbreviation | Sci Rep | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.page.number | 11 | |
dc.provenance | Realizada la curación de contenido 02/04/2025 | |
dc.publisher | Nature Publishing Group | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.relation.projectID | PI18/01165 | |
dc.relation.projectID | PI17/02136 | |
dc.relation.projectID | PI14/00710 | |
dc.relation.projectID | C-0060-2012 | |
dc.relation.projectID | CM19/00186 | |
dc.relation.publisherversion | https://doi.org/10.1038/s41598-021-95546-x | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Blood Glucose | |
dc.subject | Cohort Studies | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Prediabetic State | |
dc.subject | Glucose Tolerance Test | |
dc.subject.decs | Factores de Riesgo | |
dc.subject.decs | Estado Prediabético | |
dc.subject.decs | Insulina | |
dc.subject.decs | Ayuno | |
dc.subject.decs | Hígado Graso | |
dc.subject.decs | Prueba de Tolerancia a la Glucosa | |
dc.subject.decs | Diabetes Mellitus Tipo 2 | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease | |
dc.title | Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dspace.entity.type | Publication |